On the public citation graph
A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
0 signed · 1052 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.31629openalex-snapshot
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma
inferredcites →https://doi.org/10.1002/eji.200526347openalex-snapshot
PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion
inferredcites →https://doi.org/10.1002/eji.200737772openalex-snapshot
Historical insights into cytokines
inferredcites →https://doi.org/10.1007/978-3-319-67577-0_2openalex-snapshot
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment
inferredcites →https://doi.org/10.1007/s00125-013-2991-0openalex-snapshot
Molecular mechanism of action of metformin: old or new insights?
inferredcites →https://doi.org/10.1016/bs.acr.2019.03.001openalex-snapshot
Translation of cancer immunotherapy from the bench to the bedside
inferredcites →https://doi.org/10.1016/j.canlet.2013.08.016openalex-snapshot
Helicobacter pylori-induced gastric inflammation and gastric cancer
inferredcites →https://doi.org/10.1016/j.cell.2015.08.016openalex-snapshot
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
inferredcites →https://doi.org/10.1016/j.chom.2013.07.007openalex-snapshot
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
inferredcites →https://doi.org/10.1016/j.coi.2017.04.004openalex-snapshot
The role of AMPK in T cell metabolism and function
inferredcites →https://doi.org/10.1016/j.cytogfr.2009.07.004openalex-snapshot
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
inferredcites →https://doi.org/10.1016/j.cytogfr.2014.11.008openalex-snapshot
The use of interferon in melanoma patients: A systematic review
inferredcites →https://doi.org/10.1016/j.drudis.2016.12.003openalex-snapshot
Targeting amino acid metabolism for cancer therapy
inferredcites →https://doi.org/10.1016/j.neo.2017.08.004openalex-snapshot
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
inferredcites →https://doi.org/10.1016/j.semradonc.2014.07.005openalex-snapshot
Radiotherapy and Immunogenic Cell Death
inferredcites →https://doi.org/10.1016/j.vaccine.2018.04.066openalex-snapshot
The influence of the intestinal microbiome on vaccine responses
inferredcites →https://doi.org/10.1016/s0093-3619(08)70546-xopenalex-snapshot
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
inferredcites →https://doi.org/10.1016/s0140-6736(18)30533-6openalex-snapshot
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
inferredcites →https://doi.org/10.1016/s0140-6736(18)30789-xopenalex-snapshot
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
inferredcites →https://doi.org/10.1016/s1470-2045(18)30700-9openalex-snapshot
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(18)30952-5openalex-snapshot
Modulating the microbiome to improve therapeutic response in cancer
inferredcites →https://doi.org/10.1016/s1470-2045(19)30274-8openalex-snapshot
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
inferredcites →https://doi.org/10.1016/s1470-2045(19)30413-9openalex-snapshot
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
inferredcites →https://doi.org/10.1038/nature05414openalex-snapshot
An obesity-associated gut microbiome with increased capacity for energy harvest
inferredcites →https://doi.org/10.1038/nature10755openalex-snapshot
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
inferredcites →https://doi.org/10.1038/nature12347openalex-snapshot
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
inferredcites →https://doi.org/10.1038/nature23003openalex-snapshot
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
inferredcites →https://doi.org/10.1038/nature25979openalex-snapshot
Extensive impact of non-antibiotic drugs on human gut bacteria
inferredcites →https://doi.org/10.1038/ncomms10391openalex-snapshot
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
inferredcites →https://doi.org/10.1038/ncomms7692openalex-snapshot
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
inferredcites →https://doi.org/10.1038/ncponc0880openalex-snapshot
What are the indications for sorafenib treatment in patients with renal cell carcinoma?
inferredcites →https://doi.org/10.1038/ncponc0926openalex-snapshot
Interleukin 2 for patients with renal cancer
inferredcites →https://doi.org/10.1038/nm.2015openalex-snapshot
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
inferredcites →https://doi.org/10.1038/nm.3161openalex-snapshot
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
inferredcites →https://doi.org/10.1038/nrclinonc.2016.60openalex-snapshot
Cancer metabolism: a therapeutic perspective
inferredcites →https://doi.org/10.1038/nrclinonc.2017.101openalex-snapshot
The immune contexture in cancer prognosis and treatment
inferredcites →https://doi.org/10.1038/nrd4663openalex-snapshot
Oncolytic viruses: a new class of immunotherapy drugs
inferredcites →https://doi.org/10.1038/nri.2017.131openalex-snapshot
Towards personalized, tumour-specific, therapeutic vaccines for cancer
inferredcites →https://doi.org/10.1038/s41388-020-1240-5openalex-snapshot
MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression
inferredcites →https://doi.org/10.1038/s41467-019-12628-1openalex-snapshot
Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
inferredcites →https://doi.org/10.1038/s41571-018-0142-8openalex-snapshot
Cancer immunoediting and resistance to T cell-based immunotherapy
inferredcites →https://doi.org/10.1038/s41591-018-0238-9openalex-snapshot
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
inferredcites →https://doi.org/10.1038/s41591-018-0321-2openalex-snapshot
Translation control of the immune checkpoint in cancer and its therapeutic targeting
inferredcites →https://doi.org/10.1053/j.gastro.2017.08.022openalex-snapshot
Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice
inferredcites →https://doi.org/10.1056/nejmc1614298openalex-snapshot
Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab
inferredcites →https://doi.org/10.1056/nejmc1703047openalex-snapshot
Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade
inferredcites →https://doi.org/10.1056/nejmoa063842openalex-snapshot
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
inferredcites →https://doi.org/10.1056/nejmoa1709684openalex-snapshot
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1712126openalex-snapshot
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
inferredcites →https://doi.org/10.1056/nejmoa1910836openalex-snapshot
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
inferredcites →https://doi.org/10.1073/pnas.1717439115openalex-snapshot
Translational control in the tumor microenvironment promotes lung metastasis: Phosphorylation of eIF4E in neutrophils
inferredcites →https://doi.org/10.1080/2162402x.2018.1434468openalex-snapshot
The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
inferredcites →https://doi.org/10.1080/2162402x.2019.1568812openalex-snapshot
Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors
inferredcites →https://doi.org/10.1080/21645515.2017.1412896openalex-snapshot
Talimogene laherparepvec: First in class oncolytic virotherapy
inferredcites →https://doi.org/10.1093/annonc/mdx108openalex-snapshot
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
inferredcites →https://doi.org/10.1093/annonc/mdx225openalex-snapshot
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
inferredcites →https://doi.org/10.1093/annonc/mdy103openalex-snapshot
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
inferredcites →https://doi.org/10.1093/annonc/mdz224openalex-snapshot
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
inferredcites →https://doi.org/10.1126/science.1240527openalex-snapshot
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
inferredcites →https://doi.org/10.1126/science.1240537openalex-snapshot
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
inferredcites →https://doi.org/10.1126/science.1241214openalex-snapshot
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
inferredcites →https://doi.org/10.1126/science.aad1329openalex-snapshot
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
inferredcites →https://doi.org/10.1126/science.aaf1490openalex-snapshot
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
inferredcites →https://doi.org/10.1126/science.aah3648openalex-snapshot
Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
inferredcites →https://doi.org/10.1126/science.aah5043openalex-snapshot
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
inferredcites →https://doi.org/10.1126/science.aan3706openalex-snapshot
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
inferredcites →https://doi.org/10.1126/science.aan4236openalex-snapshot
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
inferredcites →https://doi.org/10.1126/science.aao3290openalex-snapshot
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
inferredcites →https://doi.org/10.1136/gutjnl-2017-313789openalex-snapshot
Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction
inferredcites →https://doi.org/10.1158/0008-5472.can-08-2654openalex-snapshot
Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
inferredcites →https://doi.org/10.1158/0008-5472.can-11-3722openalex-snapshot
Exploiting the Mutanome for Tumor Vaccination
inferredcites →https://doi.org/10.1158/0008-5472.can-12-3696openalex-snapshot
The Emerging “Hallmarks” of Metabolic Reprogramming and Immune Evasion: Distinct or Linked?
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-1507openalex-snapshot
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
inferredcites →https://doi.org/10.1158/1078-0432.ccr-18-2882openalex-snapshot
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0400openalex-snapshot
Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions
inferredcites →https://doi.org/10.1172/jci99036openalex-snapshot
B cells as biomarkers: predicting immune checkpoint therapy adverse events
inferredcites →https://doi.org/10.1186/s13045-018-0644-yopenalex-snapshot
Targeting the IDO1 pathway in cancer: from bench to bedside
inferredcites →https://doi.org/10.1186/s13045-018-0647-8openalex-snapshot
Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
inferredcites →https://doi.org/10.1186/s13073-016-0288-xopenalex-snapshot
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
inferredcites →https://doi.org/10.1186/s40425-017-0300-zopenalex-snapshot
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
inferredcites →https://doi.org/10.1186/s40425-018-0375-1openalex-snapshot
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
inferredcites →https://doi.org/10.1186/s40425-018-0412-0openalex-snapshot
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
inferredcites →https://doi.org/10.1200/jco.18.01998openalex-snapshot
Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial
inferredcites →https://doi.org/10.1200/jco.2011.29.15_suppl.2505openalex-snapshot
Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.9096openalex-snapshot
Correlation of absolute and relative eosinophil counts with immune-related adverse events in melanoma patients treated with ipilimumab.
inferredcites →https://doi.org/10.1200/jco.2017.77.6385openalex-snapshot
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
inferredcites →https://doi.org/10.1200/jco.2018.36.15_suppl.9532openalex-snapshot
Activity of targeted therapy after failure of first-line immunotherapy in BRAF-mutant metastatic melanoma.
inferredcites →https://doi.org/10.1200/jco.2018.36.15_suppl.9558openalex-snapshot
Chemoimmunotherapy combination after PD-1 inhibitor failure to improve clinical outcomes in metastatic melanoma patients.
inferredcites →https://doi.org/10.1200/jco.2018.79.0006openalex-snapshot
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1200/jop.2017.027326openalex-snapshot
Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy
inferredcites →https://doi.org/10.18632/oncotarget.20030openalex-snapshot
Excellent response to chemotherapy post immunotherapy
inferredcites →https://doi.org/10.18632/oncotarget.23217openalex-snapshot
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
inferredcites →https://doi.org/10.3389/fimmu.2017.00270openalex-snapshot
Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
inferredcites →https://doi.org/10.3390/cancers12030546openalex-snapshot
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.3390/cancers3043856openalex-snapshot
Cytokines in Cancer Immunotherapy
inferredcites →https://doi.org/10.3390/ijms18091887openalex-snapshot
Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer
inferredcites →https://doi.org/10.3390/vaccines4040046openalex-snapshot
Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
inferredcites →https://doi.org/10.3892/ol.2019.9899openalex-snapshot
Impact of prior antibiotic use on the efficacy of nivolumab for non‑small cell lung cancer
inferredcites →https://doi.org/10.4172/2168-9296.1000183openalex-snapshot
Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9781119603207.ch4openalex-snapshot
How Should Secondary Causes of Diabetes Be Excluded?
inferred← citeshttps://doi.org/10.1002/9781119894407.ch6openalex-snapshot
Advancements in Bioprinting for Medical Applications
inferred← citeshttps://doi.org/10.1002/9783527832095.ch23openalex-snapshot
Biomimetic Catechol‐Based Nanomaterials for Combined Anticancer Therapies
inferred← citeshttps://doi.org/10.1002/9783527838394.ch13openalex-snapshot
Cancer Vaccines Based on mRNA: Hype or Hope?
inferred← citeshttps://doi.org/10.1002/adbi.202200293openalex-snapshot
Nuclear Imaging of CAR T Immunotherapy to Solid Tumors: In Terms of Biodistribution, Viability, and Cytotoxic Effect
inferred← citeshttps://doi.org/10.1002/adfm.202102234openalex-snapshot
Oxygen‐Generating Cryogels Restore T Cell Mediated Cytotoxicity in Hypoxic Tumors
inferred← citeshttps://doi.org/10.1002/adfm.202210644openalex-snapshot
Programmed Catalytic Therapy and Antigen Capture‐Mediated Dendritic Cells Harnessing Cancer Immunotherapies by In Situ‐Forming Adhesive Nanoreservoirs
inferred← citeshttps://doi.org/10.1002/adfm.202300199openalex-snapshot
Immunotherapeutic Hydrogel with Photothermal Induced Immunogenic Cell Death and STING Activation for Post‐Surgical Treatment
inferred← citeshttps://doi.org/10.1002/adfm.202302825openalex-snapshot
Artificial Immunogenic Cell Death Lipid Nanoparticle Functions as a Therapeutic Vaccine for Cancer
inferred← citeshttps://doi.org/10.1002/adhm.202200909openalex-snapshot
Ovalbumin and Poly(i:c) Encapsulated Dendritic Cell‐Targeted Nanoparticles for Immune Activation in the Small Intestinal Lymphatic System
inferred← citeshttps://doi.org/10.1002/adhm.202202400openalex-snapshot
Advances in Lipid‐Based Codelivery Systems for Cancer and Inflammatory Diseases
inferred← citeshttps://doi.org/10.1002/adhm.202400323openalex-snapshot
Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
inferred← citeshttps://doi.org/10.1002/adhm.71715openalex-snapshot
Liposome Loaded With Yeast‐Derived Nanoparticles for the Enhanced Photothermal‐Immunotherapy of Malignant Lymphoma
inferred← citeshttps://doi.org/10.1002/adma.202303979openalex-snapshot
A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells
inferred← citeshttps://doi.org/10.1002/adtp.202300255openalex-snapshot
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
inferred← citeshttps://doi.org/10.1002/advs.202520332openalex-snapshot
Identifying Cytokine Motif‐Containing, Immunomodulatory Bacterial Proteins in Human Gut Microbiome
inferred← citeshttps://doi.org/10.1002/agm2.12342openalex-snapshot
Fasting and calorie restriction modulate age‐associated immunosenescence and inflammaging
inferred← citeshttps://doi.org/10.1002/agt2.70080openalex-snapshot
Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
inferred← citeshttps://doi.org/10.1002/ange.202311590openalex-snapshot
Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics
inferred← citeshttps://doi.org/10.1002/anie.202311590openalex-snapshot
Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics
inferred← citeshttps://doi.org/10.1002/biot.202200135openalex-snapshot
A single‐cell surgery microfluidic device for transplanting tumor cytoplasm into dendritic cells without nuclei mixing
inferred← citeshttps://doi.org/10.1002/btm2.10651openalex-snapshot
Siglec15/ TGF ‐β bispecific antibody mediates synergistic anti‐tumor response against 4T1 triple negative breast cancer in mice
inferred← citeshttps://doi.org/10.1002/cam4.4468openalex-snapshot
Immunotherapies for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6268openalex-snapshot
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
inferred← citeshttps://doi.org/10.1002/cam4.70155openalex-snapshot
Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
inferred← citeshttps://doi.org/10.1002/cbdv.202301492openalex-snapshot
Efficacy of Rotundic Acid and Its Derivatives as Promising Natural Anticancer Triterpenoids: A Literature‐Based Study
inferred← citeshttps://doi.org/10.1002/chem.202403508openalex-snapshot
Supramolecular Assemblies via Host‐Guest Interactions for Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1002/chem.202500364openalex-snapshot
Glycan Covalent Targeting Chimera‐Based T‐Cell Glycoengineering for Boosting Immunotherapy
inferred← citeshttps://doi.org/10.1002/cmdc.202200201openalex-snapshot
Copper Nanocluster Enables Simultaneous Photodynamic and Chemo Therapy for Effective Cancer Diagnosis and Treatment in Vitro
inferred← citeshttps://doi.org/10.1002/cpt.2770openalex-snapshot
From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/cpt.3379openalex-snapshot
Disentangling Anti‐Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab
inferred← citeshttps://doi.org/10.1002/eji.202250302openalex-snapshot
Immunomodulatory activity of dipeptidyl peptidase‐4 inhibitors in immune‐related diseases
inferred← citeshttps://doi.org/10.1002/exp.20210089openalex-snapshot
Advanced bioactive nanomaterials for biomedical applications
inferred← citeshttps://doi.org/10.1002/exp.20210106openalex-snapshot
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/ijc.34218openalex-snapshot
A multi‐omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti‐PD1 response in solid tumors
inferred← citeshttps://doi.org/10.1002/imed.1041openalex-snapshot
Metabolic inhibitor screening identifies dihydrofolate reductase as an inducer of the tumor immune escape mediator CD24
inferred← citeshttps://doi.org/10.1002/jev2.12433openalex-snapshot
Extracellular vesicles as human therapeutics: A scoping review of the literature
inferred← citeshttps://doi.org/10.1002/jev2.70322openalex-snapshot
Eliminating PD‐L1 on Dendritic Cell Extracellular Vesicles for Immunotherapy Potentiates Immune‐Mediated Tumour Rejection in Mice
inferred← citeshttps://doi.org/10.1002/jssc.70111openalex-snapshot
Construction of a Simplex Search Framework for the Development of a New Specific and Robust Stability‐Indicating Reversed‐Phase High‐Performance Liquid Chromatography Assay: Application for the Stability of a Peptide‐Based Telomerase Vaccine
inferred← citeshttps://doi.org/10.1002/jvc2.445openalex-snapshot
Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report
inferred← citeshttps://doi.org/10.1002/mco2.163openalex-snapshot
Nanomedicine and versatile therapies for cancer treatment
inferred← citeshttps://doi.org/10.1002/mco2.70176openalex-snapshot
Application of Immune Checkpoint Inhibitors in Cancer
inferred← citeshttps://doi.org/10.1002/mog2.70030openalex-snapshot
Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics
inferred← citeshttps://doi.org/10.1002/ptr.7189openalex-snapshot
Boosting immune system against cancer by resveratrol
inferred← citeshttps://doi.org/10.1002/sctm.20-0242openalex-snapshot
Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells-based therapy product
inferred← citeshttps://doi.org/10.1002/smll.202306303openalex-snapshot
Bacterial Flagellum–Drug Nanoconjugates for Carrier‐Free Immunochemotherapy
inferred← citeshttps://doi.org/10.1002/smll.202401631openalex-snapshot
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
inferred← citeshttps://doi.org/10.1002/smsc.202400234openalex-snapshot
Nanosecond Laser Pulses Facilitating Efficient and Specific Cell Killing with Doxorubicin‐Loaded Gold Nanoparticles Targeted to the Folate Receptor
inferred← citeshttps://doi.org/10.1002/tox.24247openalex-snapshot
Regulatory T cells subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis and treatment strategy in melanoma
inferred← citeshttps://doi.org/10.1002/viw.20250107openalex-snapshot
Organoid‐based novel technology for antitumor drug screening
inferred← citeshttps://doi.org/10.1002/wnan.1928openalex-snapshot
Imaging and monitoring of granzyme B in the immune response
inferred← citeshttps://doi.org/10.1002/wsbm.1585openalex-snapshot
Evolution of precision oncology‐guided treatment paradigms
inferred← citeshttps://doi.org/10.1007/164_2023_685openalex-snapshot
Nanomedicine – Immune System Interactions: Limitations and Opportunities for the Treatment of Cancer
inferred← citeshttps://doi.org/10.1007/16833_2024_202openalex-snapshot
Immunotherapy in Oncology: A Comprehensive Overview from a Pathological Perspective
inferred← citeshttps://doi.org/10.1007/16833_2024_339openalex-snapshot
Nanomedicine-Based Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/16833_2024_422openalex-snapshot
Biomaterials and Nanomedicines: Progress in Cancer Research
inferred← citeshttps://doi.org/10.1007/978-1-0716-2441-8_12openalex-snapshot
NK Cell Effector Functions and Bystander Tumor Cell Killing in Immunovirotherapy
inferred← citeshttps://doi.org/10.1007/978-1-0716-2986-4_13openalex-snapshot
Statistical and Computational Methods for Proteogenomic Data Analysis
inferred← citeshttps://doi.org/10.1007/978-1-0716-3577-3_4openalex-snapshot
Metastasis Models: Thermodynamics and Complexity
inferred← citeshttps://doi.org/10.1007/978-1-0716-4402-7_6openalex-snapshot
Immune Cell Homing Hydrogels for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-71113-9_39-1openalex-snapshot
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
inferred← citeshttps://doi.org/10.1007/978-3-030-76201-8_16openalex-snapshot
Systemic Therapy, Trials, and Future Directions for Chordoma of the Spine
inferred← citeshttps://doi.org/10.1007/978-3-030-78117-0_16openalex-snapshot
Cell Therapy for Uveal Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_1-1openalex-snapshot
Introduction to Cancer Immunology
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_170-1openalex-snapshot
ImmunoPET Imaging of Immune Checkpoints to Assess Their Cancer Therapeutic Potential
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_170-2openalex-snapshot
ImmunoPET Imaging of Immune Checkpoints to Assess Their Cancer Therapeutic Potential
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_180-1openalex-snapshot
Introduction on Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_190-1openalex-snapshot
CAR Exosome-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_241-1openalex-snapshot
Immunotherapy for Ocular Tumors
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_334-1openalex-snapshot
Challenges in Computational Pathology of Biomarker-Driven Predictive and Prognostic Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_343-1openalex-snapshot
Gastrointestinal Side Effects of Anticancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_387-1openalex-snapshot
Potential of Patient-Derived Organoids and Other 3D Culture Models to Assess Immunotherapy Response in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_403-1openalex-snapshot
RBPJ Role in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-97393-3_11openalex-snapshot
Clinical Implications of Multi-level (Scalar) Disorganisation in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-29119-7_11openalex-snapshot
T-Cell Receptor Optimization with Reinforcement Learning and Mutation Polices for Precision Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-76882-8_39openalex-snapshot
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
inferred← citeshttps://doi.org/10.1007/978-3-031-86002-7_23openalex-snapshot
PD-1/PD-L1 Inhibitors and Triple-Negative Breast Cancer (TNBC): A Review
inferred← citeshttps://doi.org/10.1007/978-3-031-97242-3_1openalex-snapshot
Cancer Immunotherapy—An Overview
inferred← citeshttps://doi.org/10.1007/978-3-032-00749-0_1openalex-snapshot
Introduction to Cancer Immunology
inferred← citeshttps://doi.org/10.1007/978-3-032-00763-6_387openalex-snapshot
Potential of Patient-Derived Organoids and Other 3D Culture Models to Assess Immunotherapy Response in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_170openalex-snapshot
ImmunoPET Imaging of Immune Checkpoints to Assess Their Cancer Therapeutic Potential
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_180openalex-snapshot
Introduction on Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_190openalex-snapshot
CAR Exosome-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_403openalex-snapshot
RBPJ Role in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_241openalex-snapshot
Immunotherapy for Ocular Tumors
inferred← citeshttps://doi.org/10.1007/978-3-032-00775-9_334openalex-snapshot
Challenges in Computational Pathology of Biomarker-Driven Predictive and Prognostic Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-032-00775-9_343openalex-snapshot
Gastrointestinal Side Effects of Anticancer Therapy
inferred← citeshttps://doi.org/10.1007/978-981-16-1892-5_14openalex-snapshot
Synthesis and Development of Platinum-Based Anticancer Drugs
inferred← citeshttps://doi.org/10.1007/978-981-16-4921-9_150-1openalex-snapshot
Green Nanoparticles in Drug Delivery of Cancer Therapy, Biomedical Applications
inferred← citeshttps://doi.org/10.1007/978-981-92-0477-9_7openalex-snapshot
Harnessing the Power of CAR-T Cells in Hematologic and Solid Tumors
inferred← citeshttps://doi.org/10.1007/978-981-96-4959-4_14openalex-snapshot
Biotechnology in Drug Discovery and Development for Cancer
inferred← citeshttps://doi.org/10.1007/978-981-96-7336-0_7openalex-snapshot
Inflammation as a Target in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-981-97-4618-7_150openalex-snapshot
Green Nanoparticles in Drug Delivery of Cancer Therapy and Biomedical Applications
inferred← citeshttps://doi.org/10.1007/978-981-97-7022-9_17openalex-snapshot
Regulatory Aspects of Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-99-2196-6_54-1openalex-snapshot
Pharmacogenomics in Oncology: Current Challenges and Future Strategies
inferred← citeshttps://doi.org/10.1007/978-981-99-2196-6_79-1openalex-snapshot
Advanced Therapeutic Approaches in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-981-99-6263-1_54openalex-snapshot
Pharmacogenomics in Oncology: Current Challenges and Future Strategies
inferred← citeshttps://doi.org/10.1007/978-981-99-6263-1_79openalex-snapshot
Advanced Therapeutic Approaches in Cancer Therapy
inferred← citeshttps://doi.org/10.1007/s00018-023-05098-8openalex-snapshot
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s00066-022-02028-8openalex-snapshot
Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines
inferred← citeshttps://doi.org/10.1007/s00092-022-5501-1openalex-snapshot
Immunbedingte Toxizitäten behandeln
inferred← citeshttps://doi.org/10.1007/s00228-024-03647-zopenalex-snapshot
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1007/s00259-024-06896-3openalex-snapshot
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β
inferred← citeshttps://doi.org/10.1007/s00262-021-02887-7openalex-snapshot
Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy
inferred← citeshttps://doi.org/10.1007/s00262-021-03004-4openalex-snapshot
Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity
inferred← citeshttps://doi.org/10.1007/s00262-021-03046-8openalex-snapshot
Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update
inferred← citeshttps://doi.org/10.1007/s00262-023-03606-0openalex-snapshot
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions
inferred← citeshttps://doi.org/10.1007/s00262-024-03889-xopenalex-snapshot
Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model
inferred← citeshttps://doi.org/10.1007/s00285-022-01851-yopenalex-snapshot
Two-phase model of compressive stress induced on a surrounding hyperelastic medium by an expanding tumour
inferred← citeshttps://doi.org/10.1007/s00432-022-04268-8openalex-snapshot
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00432-023-04659-5openalex-snapshot
Immune checkpoint inhibitor-induced hypophysitis: clinical and biochemical features
inferred← citeshttps://doi.org/10.1007/s00894-026-06642-6openalex-snapshot
Exploring FDA-approved small molecules for their potential as PD-1/PD-L1 inhibitors: integrating computational screening with experimental testing
inferred← citeshttps://doi.org/10.1007/s10238-026-02083-wopenalex-snapshot
NK cell–associated LncRNA signature predicts prognosis and immune landscape in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s10495-024-02022-8openalex-snapshot
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
inferred← citeshttps://doi.org/10.1007/s10529-023-03461-0openalex-snapshot
Recent advances and current challenges in CAR-T cell therapy
inferred← citeshttps://doi.org/10.1007/s10637-020-01039-5openalex-snapshot
Nephrotoxicity in patients with solid tumors treated with anti-PD-1/PD-L1 monoclonal antibodies: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10637-022-01243-5openalex-snapshot
Effects of Nivolumab and Ipilimumab on the suppression of cisplatin resistant small cell lung cancer cells
inferred← citeshttps://doi.org/10.1007/s10911-023-09546-wopenalex-snapshot
Gestational Breast Cancer – a Review of Outcomes, Pathophysiology, and Model Systems
inferred← citeshttps://doi.org/10.1007/s11033-026-11828-5openalex-snapshot
Role of ferroptosis on immunotherapy in breast cancer
inferred← citeshttps://doi.org/10.1007/s11060-023-04491-4openalex-snapshot
Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy
inferred← citeshttps://doi.org/10.1007/s11192-024-05161-6openalex-snapshot
Comparative science mapping: a novel conceptual structure analysis with metadata
inferred← citeshttps://doi.org/10.1007/s11431-023-2574-0openalex-snapshot
Nanomedicine-mediated immunogenic cell death and its combination with immune checkpoint blockade therapy
inferred← citeshttps://doi.org/10.1007/s11538-025-01433-1openalex-snapshot
The Impact of T-cell Exhaustion Dynamics on Tumour–Immune Interactions and Tumour Growth
inferred← citeshttps://doi.org/10.1007/s11864-022-00995-9openalex-snapshot
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
inferred← citeshttps://doi.org/10.1007/s11864-023-01066-3openalex-snapshot
Can Immune Therapy Cure Acute Myeloid Leukemia?
inferred← citeshttps://doi.org/10.1007/s12026-026-09824-9openalex-snapshot
Overcoming resistance to immune checkpoint inhibitors in cancer: translational mechanisms, dynamic biomarkers, clinically actionable combination strategies, and comparative checkpoint biology
inferred← citeshttps://doi.org/10.1007/s12032-023-02066-xopenalex-snapshot
NK cells direct the perspective approaches to cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s12032-023-02068-9openalex-snapshot
Current perspectives on Vaxinia virus: an immuno-oncolytic vector in cancer therapy
inferred← citeshttps://doi.org/10.1007/s12032-024-02362-0openalex-snapshot
A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases
inferred← citeshttps://doi.org/10.1007/s12032-025-02808-zopenalex-snapshot
Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectives
inferred← citeshttps://doi.org/10.1007/s12094-025-04000-1openalex-snapshot
First unscheduled hospitalization in advanced cancer as a prognostic indicator of poor survival and trigger for palliative care referral
inferred← citeshttps://doi.org/10.1007/s12272-022-01387-1openalex-snapshot
Function and therapeutic development of exosomes for cancer therapy
inferred← citeshttps://doi.org/10.1007/s12274-022-4282-xopenalex-snapshot
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
inferred← citeshttps://doi.org/10.1007/s12282-022-01368-8openalex-snapshot
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update
inferred← citeshttps://doi.org/10.1007/s12282-025-01793-5openalex-snapshot
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances
inferred← citeshttps://doi.org/10.1007/s12291-023-01166-9openalex-snapshot
Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/s12672-024-01272-xopenalex-snapshot
Nanocurcumin in cancer treatment: a comprehensive systematic review
inferred← citeshttps://doi.org/10.1007/s12672-026-04407-4openalex-snapshot
VISTA: bridging gaps in cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s13205-025-04502-3openalex-snapshot
Antitumor potential of silver nanoparticles against lung cancer: current trends, scope and relevance
inferred← citeshttps://doi.org/10.1007/s13258-023-01463-wopenalex-snapshot
SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration
inferred← citeshttps://doi.org/10.1007/s13346-023-01311-0openalex-snapshot
Microneedles: structure, classification, and application in oral cancer theranostics
inferred← citeshttps://doi.org/10.1007/s40005-022-00569-9openalex-snapshot
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s40430-026-06456-wopenalex-snapshot
Impact of infusion strategies and tumor morphology on the pharmacokinetics of liposomal drug distribution: a quantitative analysis of mass diffusion in intratumoral drug delivery
inferred← citeshttps://doi.org/10.1007/s40820-020-00482-6openalex-snapshot
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
inferred← citeshttps://doi.org/10.1007/s40843-024-2940-6openalex-snapshot
Minimalist “in situ” tumor vaccine leveraging versatile dendrimer nanoplatform coordinated ICD and immunoagonist for boosted chemoimmunotherapy
inferred← citeshttps://doi.org/10.1007/s41127-024-00079-5openalex-snapshot
Optoelectronic tuning of two-dimensional engineered nanomaterials for enhanced photothermal therapy: opportunities and challenges
inferred← citeshttps://doi.org/10.1007/s42000-025-00738-zopenalex-snapshot
A synergistic drug combination that aids our battle against anaplastic thyroid carcinoma: a case report and discussion
inferred← citeshttps://doi.org/10.1007/s42452-026-08439-xopenalex-snapshot
Expanding horizons of immunotherapy: from oncology to multisystemic applications
inferred← citeshttps://doi.org/10.1007/s42860-021-00165-2openalex-snapshot
Binding of DNA to Natural Sepiolite: Applications in Biotechnology and Perspectives
inferred← citeshttps://doi.org/10.1007/s43440-026-00857-3openalex-snapshot
Redox rewiring in glioblastoma: the thioredoxin system as a precision therapeutic target
inferred← citeshttps://doi.org/10.1007/s43472-025-00182-9openalex-snapshot
Nebenwirkungen von Immuncheckpoint-Inhibitoren in der Gastroenterologie
inferred← citeshttps://doi.org/10.1007/s44178-024-00098-5openalex-snapshot
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for locally advanced head and neck squamous cell carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-823686-4.00018-5openalex-snapshot
Recent developments in cancer vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-85781-9.00017-8openalex-snapshot
Targeted photodynamic immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-87763-3.00020-4openalex-snapshot
The microbiome and cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-89868-3.00004-5openalex-snapshot
Polymeric micelles as delivery systems for anticancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-90949-5.00007-3openalex-snapshot
Proteomic biomarker technology for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-91668-4.00014-9openalex-snapshot
Metal-based drug delivery systems for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-15280-1.00018-2openalex-snapshot
Repurposing cardiac glycosides as the hallmark of immunogenic modulators in cancer therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-15502-4.00006-9openalex-snapshot
Chemical therapies, immunotherapy, and new treatment strategies for allergic asthma
inferred← citeshttps://doi.org/10.1016/b978-0-443-15518-5.00021-5openalex-snapshot
Cancer nanoimmunotherapy in the present scenario
inferred← citeshttps://doi.org/10.1016/b978-0-443-15526-0.00009-3openalex-snapshot
A new frontier in cancer therapy: The intersection of cancer vaccines and metabolomics
inferred← citeshttps://doi.org/10.1016/b978-0-443-21521-6.00005-3openalex-snapshot
Cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-22253-5.00013-3openalex-snapshot
Nanomaterial-based cancer immunotheranostics
inferred← citeshttps://doi.org/10.1016/b978-0-443-23523-8.00022-5openalex-snapshot
Application of artificial intelligence and machine learning in pancreatic cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-24742-2.00007-1openalex-snapshot
Delivery strategies of immunotherapies in the treatment of colorectal cancer
inferred← citeshttps://doi.org/10.1016/b978-0-443-33302-6.00011-1openalex-snapshot
Role of gene therapy and immunotherapy in precision medicine
inferred← citeshttps://doi.org/10.1016/b978-0-443-44579-8.00024-2openalex-snapshot
Current perspectives of nanovaccines in cancer treatment
inferred← citeshttps://doi.org/10.1016/bs.acr.2022.12.001openalex-snapshot
Epigenetically programmed resistance to chemo- and immuno-therapies
inferred← citeshttps://doi.org/10.1016/bs.ai.2024.10.002openalex-snapshot
B-cell editing: An emerging alternative of precision oncotherapy
inferred← citeshttps://doi.org/10.1016/bs.ai.2024.10.008openalex-snapshot
Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.apcsb.2021.11.008openalex-snapshot
In silico tools and databases for designing cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2023.03.005openalex-snapshot
Radiation therapy-activated nanoparticle and immunotherapy: The next milestone in oncology?
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2023.05.009openalex-snapshot
Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis
inferred← citeshttps://doi.org/10.1016/j.actbio.2023.02.011openalex-snapshot
Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy
inferred← citeshttps://doi.org/10.1016/j.actbio.2023.10.002openalex-snapshot
Injectable hydrogels for personalized cancer immunotherapies
inferred← citeshttps://doi.org/10.1016/j.actbio.2024.12.048openalex-snapshot
Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping
inferred← citeshttps://doi.org/10.1016/j.actbio.2026.05.017openalex-snapshot
A cascade-responsive nanoplatform for cyclooxygenase-2 inhibition and inflammation regulation to enhance photoimmunotherapy
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113954openalex-snapshot
Dynamic nanoassemblies of nanomaterials for cancer photomedicine
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114344openalex-snapshot
Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114495openalex-snapshot
The promising interplay between sonodynamic therapy and nanomedicine
inferred← citeshttps://doi.org/10.1016/j.addr.2026.115918openalex-snapshot
Microfluidic platforms for preclinical evaluation of immunotherapies
inferred← citeshttps://doi.org/10.1016/j.adro.2024.101457openalex-snapshot
Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT)
inferred← citeshttps://doi.org/10.1016/j.apmt.2021.101217openalex-snapshot
Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives
inferred← citeshttps://doi.org/10.1016/j.arcmed.2022.11.008openalex-snapshot
Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy
inferred← citeshttps://doi.org/10.1016/j.asoc.2024.112368openalex-snapshot
Differential neural network based adaptive average output feedback control design for dosage determination on cancer based immunotherapy treatment
inferred← citeshttps://doi.org/10.1016/j.bbadis.2024.167486openalex-snapshot
Nanomolecular machines: Pioneering precision medicine for neoplastic diseases through advanced diagnosis and treatment
inferred← citeshttps://doi.org/10.1016/j.bbcan.2022.188827openalex-snapshot
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.188896openalex-snapshot
Regulation of cGAS-STING signalling in cancer: Approach for combination therapy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189155openalex-snapshot
Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189433openalex-snapshot
Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2026.189640openalex-snapshot
Programming regulated cell death to engineer whole-tumor-cell vaccines for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2022.08.016openalex-snapshot
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2025.01.028openalex-snapshot
Iterative selection of lipid nanoparticle vaccine adjuvants for rapid elicitation of tumoricidal CD8⁺ T cells
inferred← citeshttps://doi.org/10.1016/j.bioadv.2023.213733openalex-snapshot
Chitosan and hyaluronic acid-based nanocarriers for advanced cancer therapy and intervention
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123336openalex-snapshot
Targeting myeloid cells with platelet-derived extracellular vesicles to overcome resistance of immune checkpoint blockade therapy
showing the first 200 of 953 · page through all 953
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.